Bleeding and Neurologic Complications in 58,000 Interventional Pain Procedures
- 1 January 2017
- journal article
- research article
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 42 (6) , 782-787
Abstract
Background and Objectives Interventional pain procedures are commonly performed on patients receiving antiplatelet therapy. However, there is limited evidence to support or refute the safety of this practice. The goal of this investigation was to assess the rate of bleeding complications in a large cohort of patients undergoing intermediate- and low-risk pain procedures, with a specific focus on antiplatelet and anticoagulant medication use and baseline coagulation abnormalities. Methods This is a retrospective cohort study of adult patients undergoing low- and intermediate-risk pain procedures from 2005 through 2014 by the division of pain medicine at a single academic tertiary care center. Baseline characteristics, antiplatelet and anticoagulant medication use, coagulation parameters, and procedural details were extracted from the electronic medical record. The primary outcome was a bleeding-related complication requiring emergency medicine, neurology, or neurosurgical evaluation within 31 days. The secondary outcome was the presence or absence of a periprocedural red blood cell transfusion occurring within 72 hours of needle placement. Results A total of 58,066 procedures were performed on 24,590 unique patients. Preprocedural aspirin or nonsteroidal anti-inflammatory drug therapy was present for 17,825 procedures (30.7%). Sixteen procedures were associated with perioperative red blood cell transfusion (0.03%), with no difference based on preprocedural nonsteroidal anti-inflammatory drug, including aspirin, or other anticoagulation use (P = 0.107). Five patients (0.009%) had a neurologic complication requiring further evaluation, of which 2 were likely related to procedural bleeding. Conclusions Bleeding complications are rare in patients undergoing low- or intermediate-risk pain procedures even in the presence of antiplatelet medications. This is consistent with recently released guidelines.Keywords
This publication has 18 references indexed in Scilit:
- Safeguards to Prevent Neurologic Complications after Epidural Steroid InjectionsAnesthesiology, 2015
- Anatomy and Pathophysiology of Spinal Cord Injury Associated With Regional Anesthesia and Pain MedicineRegional Anesthesia & Pain Medicine, 2015
- Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant MedicationsRegional Anesthesia & Pain Medicine, 2015
- Spinal Epidural Hematoma After Spinal Cord Stimulator Trial Lead Placement in a Patient Taking AspirinRegional Anesthesia & Pain Medicine, 2014
- Epidural Hematomas After Removal of Percutaneous Spinal Cord Stimulator Trial LeadsRegional Anesthesia & Pain Medicine, 2014
- Derivation and Validation of Automated Electronic Search Strategies to Extract Charlson Comorbidities From Electronic Medical RecordsMayo Clinic Proceedings, 2012
- The Enterprise Data Trust at Mayo Clinic: a semantically integrated warehouse of biomedical dataJournal of the American Medical Informatics Association, 2010
- Executive Summary: Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic TherapyRegional Anesthesia & Pain Medicine, 2010
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007